Overall rank by patents
#26,002
Across all tracked assignees
USPTO PatentsView assignee record - 10 granted patents across 12 technology areas, active 2020–2024. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: G06Q (INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE,).
The verdict
CRC holds 10 US patents across 12 technology areas, rank #26,002 of 50,000 tracked assignees.
CRC R&D, Llc has been granted 10 US utility patents between 2020 and 2024, placing CRC R&D, Llc at rank #26,002 across all assignees tracked by PlainPatent. This portfolio spans 12 distinct Cooperative Patent Classification (CPC) subclasses, averaging 25.2 claims per patent with primary concentration in G06Q (INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE,). As a US Corporation, CRC R&D, Llc is one of the more focused assignees in the PatentsView dataset. By volume, CRC sits between Cosmecca Korea Co., Ltd. (10 patents, rank #25,998) and CSR Imaging US, Lp (10 patents, rank #26,006) - the closest US assignees by grant volume. The composite Innovation Score of 55.5/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Historical data spans 2020 through 2024, with 10 total grants over that period. Velocity comparisons require five years of historical filings to calibrate. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. CRC R&D, Llc's 25.2 average claims per patent reflects complex, broadly scoped inventions that are difficult for competitors to design around, while concentration in 12 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark CRC R&D, Llc against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
COSMECCA KOREA CO., LTD.
10 patents
COUSIN BIOTECH
10 patents
CP Kelco ApS
10 patents
CR Development AB
10 patents
CREATING NANO TECHNOLOGIES, INC.
10 patents
CREATV MICROTECH, INC.
10 patents
CRESTA INTELLIGENCE INC.
10 patents
CSR IMAGING US, LP
10 patents
CRC R&D, LLC
10 patents
What this shows CRC holds 10 patents at rank #26,002, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
CRC's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
56 Top 7% higher than 93% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2020–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2020 | 1 | 10.0% |
| 2021 | 1 | 10.0% |
| 2022 | 3 | 30.0% |
| 2023 | 4 | 40.0% |
| 2024 | 1 | 10.0% |
Top 12 of 12 technology areas
Overall rank by patents
#26,002
Across all tracked assignees
55.5 out of 100
How to use this portfolio
CRC's 10 grants land it in the top 7% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.